Prestige^® 2 with Havlogen^®

Prestige® 2 with Havlogen® aids in the prevention of respiratory disease in horses caused by equine influenza virus (EIV) and equine rhinopneumonitis (EHV-1 and EHV-4). This killed vaccine contains the proprietary adjuvant Havlogen® which is designed to increase the efficacy of protection. Prestige® 2 with Havlogen® is safe for use in healthy horses at least 6 months of age. Foals nursing immune dams should be vaccinated when maternal antibody levels will allow active immunization. No reconstitution necessary. Needles and syringes sold separately.

Ingredients: Prestige® 2 with Havlogen® contains Rhinopneumonitis EHV-1, EHV-4, Influenza (A2) KY93, KY02, Newmarket 2/93 (cross-protects against: KY91, 93, 99, 02, OH03, Suffolk 89, NM1/93 and 2/93 and South Africa 03) Vaccine, Florida 13 (FL13) and Richmond 07 (Clade 2). Neomycin, polymyxin B, nystatin and thimerosal added as preservatives.

Indications: Prestige® 2 with Havlogen® is for the vaccination of healthy horses against respiratory diseases caused by Equine Herpesvirus types 1 and 4 and Equine Influenza with Kentucky 93.

Dosage and Administration: Administer 1 ml Prestige® 2 with Havlogen® Intramuscular. Repeat the dose in 4-6 weeks. Give a 1 ml booster annually or in the event of a threatened epidemic.

Storage: Store in the dark at 2° to 7° C (35° to 45° F).

Caution: Consult a veterinarian before administering vaccines.

Shipping: Ships on ice overnight

Restrictions: Cannot ship to Canada or Puerto Rico; inquire regarding restrictions to other countries.